Functional defects in color vision in patients with choroideremia

Functional defects in color vision in patients with choroideremia

<br xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions"><strong>Purpose: </strong>To characterize defects in color vision in patients with choroideremia.</br><br xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions"><strong>Design: </s...

Full description

Bibliographic Details
Main Authors:	Jolly, J, Groppe, M, Birks, J, Downes, S, MacLaren, R
Format:	Journal article
Language:	English
Published:	Elsevier 2015

Similar Items

Structural and Functional Characteristics of Color Vision Changes in Choroideremia
by: Jasleen K. Jolly, et al.
Published: (2021-10-01)

The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype
by: Simunovic, M, et al.
Published: (2016)

Structural and functional characteristics of color vision changes in choroideremia
by: Jolly, JK, et al.
Published: (2021)

Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging
by: Jolly, J, et al.
Published: (2017)

Macular hole surgery in patients with end-stage choroideremia
by: Zinkernagel, MS, et al.
Published: (2013)

A qualitative and quantitative assessment of fundus autofluorescence patterns in patients with choroideremia
by: Jolly, J, et al.
Published: (2016)

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
by: Xue, K, et al.
Published: (2018)

Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia
by: Xue, K, et al.
Published: (2016)

Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial
by: MacLaren, R, et al.
Published: (2014)

Visual acuity after retinal gene therapy for Choroideremia
by: Edwards, T, et al.
Published: (2016)

Macular hole surgery in patients with end-stage choroideremia.
by: Zinkernagel, MS, et al.
Published: (2013)

Retinal degeneration in choroideremia follows an exponential decay function
by: Aylward, J, et al.
Published: (2018)

Recent advances and future prospects in choroideremia
by: Zinkernagel MS, et al.
Published: (2015-11-01)

AAV2/2-CBA-REP1 Vector with WPRE Provides Functional Expression of the Transgene in Choroideremia Mouse Knock-Out and Patient Cells
by: Tolmachova, T, et al.
Published: (2012)

Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector.
by: Barnard, A, et al.
Published: (2014)

Choroideremia: molecular mechanisms and development of AAV gene therapy
by: Patrício, M, et al.
Published: (2018)

Novel non-contiguous exon duplication in choroideremia
by: Edwards, T, et al.
Published: (2017)

Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
by: Wood, LJ, et al.
Published: (2021)

Prenylation of rab6a as a potency assay for choroideremia gene therapy
by: Patricio, M, et al.
Published: (2017)

Longitudinal study to assess the quantitative use of fundus autofluorescence for monitoring disease progression in choroideremia
by: Dubis, AM, et al.
Published: (2021)

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
by: Halioua-Haubold, C, et al.
Published: (2018)

A detailed in vivo analysis of the retinal nerve fibre layer in choroideremia
by: Fu, D, et al.
Published: (2018)

Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model
by: Halioua-Haubold, C-L, et al.
Published: (2019)

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.
by: Maclaren, R, et al.
Published: (2014)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
by: Han, RC, et al.
Published: (2021)

The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A
by: Patrício, M, et al.
Published: (2018)

Low‐contrast visual acuity versus low‐luminance visual acuity in choroideremia
by: Wood, L, et al.
Published: (2020)

Colour discrimination ellipses in choroideremia
by: Seitz, IP, et al.
Published: (2018)

Ocular gene therapy for choroideremia: clinical trials and future perspectives
by: Xue, K, et al.
Published: (2018)

The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A
by: Maria I. Patrício, et al.
Published: (2018-06-01)

Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.
by: Tolmachova, T, et al.
Published: (2010)

Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo
by: Tolmachova, T, et al.
Published: (2013)

Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial
by: MacLaren, RE, et al.
Published: (2023)

Blood-aqueous Barrier Function in a Patient With Choroideremia
by: Muh-Shy Chen, et al.
Published: (2010-02-01)

Gene therapy for retinal dystrophies
by: Issa, P, et al.
Published: (2012)

Genetic testing for choroideremia
by: Abeshi Andi, et al.
Published: (2017-10-01)

The Effect of Cataract on Color Vision Measurement with the Low-Vision Cambridge Colour Test
by: Jasleen K. Jolly, DPhil, MCOptom, et al.
Published: (2022-06-01)

Binocular Visual Function in a Pre-Presbyopic Patient with Uniocular Cataract Undergoing Cataract Surgery with a Multifocal Intraocular Lens
by: Wood LJ, et al.
Published: (2020-07-01)

Gene therapy for choroideremia using an adeno-associated viral vector encoding Rab escort protein 1: the REGENERATE open-label trial
by: Jasmina Cehajic-Kapetanovic, et al.
Published: (2024-05-01)

Microperimetry hill of vision and volumetric measures of retinal sensitivity
by: Josan, AS, et al.
Published: (2021)